Gastrointestinal Cancer | Specialty

Advanced CRC: Pushing the Treatment Paradigm Forward

June 20th 2018

Discerning HIPEC

June 20th 2018

Advanced CRC: Liquid Biopsies and the CRICKET Study

June 20th 2018

VALENTINO Study: Maintenance Therapy in Advanced CRC

June 20th 2018

Combination Strategies in Advanced CRC: E7208 and APOLLON

June 20th 2018

Key Investigations in Advanced Colorectal Cancer

June 20th 2018

Ramucirumab Extends Survival for AFP-Elevated HCC in Pooled Analysis

June 20th 2018

Treatment with second-line ramucirumab improved median overall survival by 3.1 months compared with placebo in patients with advanced hepatocellular carcinoma with alpha-fetoprotein levels ≥400 ng/ml.

Dr. Conroy Discusses Survival Data With FOLFIRINOX in Pancreatic Cancer

June 20th 2018

Thierry Conroy, MD, medical oncologist, director, Institut de Cancerologie de Lorraine, discusses survival data with modified FOLFIRINOX in pancreatic cancer.

Dr. Finn Discusses the Pooled Analysis of REACH and REACH-2 in HCC

June 20th 2018

Richard S. Finn, MD, assistant professor of medicine, Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California, Los Angeles, discusses the pooled analysis of the REACH and REACH-2 studies in patients with hepatocellular carcinoma.

Dr. Bekaii-Saab on Immunotherapy in Colorectal Cancer

June 18th 2018

Tanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, discusses the use of immunotherapy in patients with microsatellite stable colorectal cancer.

Adjuvant Chemotherapy Advances Boost Outcomes in GI Malignancies

June 18th 2018

Diane Reidy-Lagunes, MD, outlines the current state-of-the-art gastrointestinal care.

Patients Aged

June 13th 2018

Patients younger than 65 years experienced net cancer costs that were higher for breast, colorectal, lung, and prostate cancer compared with patients who were 65 years and older.

Status Report: Expert Reviews Guideline-Based Options in Advanced CRC

June 13th 2018

There are pivotal developments in colorectal cancer that have shaped the National Comprehensive Cancer Network guidelines in the past several years.

It's Not Quite Prime Time for Up-Front Genomic Sequencing in Early-Stage CRC

June 11th 2018

Although testing for some genetic defects has been incorporated into the treatment paradigm, the clinical utility of up-front tumor sequencing that would yield wide-ranging information has not yet been established.

Learning to Navigate the Neoadjuvant and Adjuvant Paradigms in Pancreatic Cancer

June 11th 2018

Tanios Bekaii-Saab, MD, discusses neoadjuvant and adjuvant strategies in treating patients with early-stage pancreatic cancer.

Amid Success, Immunotherapy Faces Challenges in GI Malignancies

June 8th 2018

Gregory L. Beatty, MD, PhD, shares his insight on the challenges with sequencing immunotherapies in light of recent advancements in gastrointestinal malignancies.

Surgery Remains Vital in Hepatobiliary Neoplasms

June 8th 2018

Theodore H. Welling, MD, discusses the expanding role of surgery in hepatobiliary neoplasms.

Dr. Conroy Discusses Adjuvant mFOLFIRINOX in Pancreatic Cancer

June 7th 2018

Thierry Conroy, MD, medical oncologist, director, Institut de Cancerologie de Lorraine, discusses the results of an adjuvant modified FOLFIRINOX regimen (mFOLFIRINOX) in patients with pancreatic cancer.

Ahn Recaps Advances and Challenges in Gastric/GEJ Cancers

June 7th 2018

Daniel Ahn, DO, discusses advances and challenges with targeted and immune-based therapies in the treatment of patients with gastric and gastroesophageal cancer.

Ramucirumab Extends Survival in Advanced HCC

June 6th 2018

Second-line ramucirumab (Cyramza) reduced the risk of death by 29% versus placebo in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein.